A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?
NG Martin, MD Snape - Expert review of vaccines, 2013 - Taylor & Francis
The first meningococcal vaccine with the potential to provide broad coverage against
serogroup B disease has recently been approved for use in Europe. This vaccine, multi …
serogroup B disease has recently been approved for use in Europe. This vaccine, multi …
[HTML][HTML] Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain …
G Frosi, A Biolchi, ML Sapio, F Rigat, S Gilchrist… - Vaccine, 2013 - Elsevier
Abstract Background 4CMenB (Bexsero), a vaccine developed against invasive
meningococcal disease caused by capsular group B strains (MenB), was recently licensed …
meningococcal disease caused by capsular group B strains (MenB), was recently licensed …
Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
I Rivero-Calle, PF Raguindin… - Infection and drug …, 2019 - Taylor & Francis
Invasive meningococcal disease (IMD) is a major public health concern because of its high
case fatality, long-term morbidity, and potential to course with outbreaks. IMD caused by …
case fatality, long-term morbidity, and potential to course with outbreaks. IMD caused by …
The capsular group B meningococcal vaccine, 4CMenB: clinical experience and potential efficacy
CS Rollier, C Dold, L Marsay… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Capsular group B meningococcal disease is a leading cause of childhood
meningitis and septicaemia. Up to 10% of sufferers die, and sequelae remain in> 30% of …
meningitis and septicaemia. Up to 10% of sufferers die, and sequelae remain in> 30% of …
[HTML][HTML] Vacunación frente al meningococo B. Posicionamiento del Comité Asesor de Vacunas de la Asociación Española de Pediatría
D Moreno-Pérez, FJÁ García, JA Fernández… - Anales de …, 2015 - Elsevier
La enfermedad meningocócica invasora, con sus 2 formas de presentación principales
(sepsis y meningitis), es una patología grave y potencialmente mortal, causada por distintos …
(sepsis y meningitis), es una patología grave y potencialmente mortal, causada por distintos …
[HTML][HTML] Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes
A Gil, D Barranco, J Batalla, JM Bayas, M Campins… - Anales de …, 2014 - Elsevier
Introducción La enfermedad meningocócica es una infección grave causada por Neisseria
meningitidis, cuyo serogrupo predominante actualmente es el B, para el que ha sido …
meningitidis, cuyo serogrupo predominante actualmente es el B, para el que ha sido …
[PDF][PDF] Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de cuatro componentes
A Gil, D Barranco, J Batalla, JM Bayas… - Pediatría Atención …, 2014 - SciELO Espana
Documento de consenso Page 1 Rev Pediatr Aten Primaria. 2014;16:108.e55-e74 ISSN:
1139-7632 • www.pap.es e55 Documento de consenso Prevención de la enfermedad …
1139-7632 • www.pap.es e55 Documento de consenso Prevención de la enfermedad …
Vaccination against meningococcal B disease. public statement of the advisory committee on vaccines of the Spanish Association of Paediatrics (CAV-AEP)
D Moreno-Pérez, FJÁ García, JA Fernández… - Anales de Pediatría …, 2015 - Elsevier
Meningococcal invasive disease, including the main clinical presentation forms (sepsis and
meningitis), is a severe and potentially lethal infection caused by different serogroups of …
meningitis), is a severe and potentially lethal infection caused by different serogroups of …
Implantación de la vacuna frente al meningococo B en el calendario vacunal. Revisión bibliográfica
QL de la Viuda - 2018 - uvadoc.uva.es
La enfermedad meningocócica producida por el serogrupo B es una patología grave y
potencialmente mortal, ocasionándose la mayoría de casos a edad infantil. Actualmente …
potencialmente mortal, ocasionándose la mayoría de casos a edad infantil. Actualmente …
[PDF][PDF] Documento de consenso
A Gila, D Barrancob, J Batallac, JM Bayasd… - Rev Pediatr, 2014 - archivos.pap.es
Documento de consenso Page 1 Rev Pediatr Aten Primaria. 2014;16:108.e55-e74 ISSN:
1139-7632 • www.pap.es e55 Documento de consenso Prevención de la enfermedad …
1139-7632 • www.pap.es e55 Documento de consenso Prevención de la enfermedad …